HOME › DRUGS › BRIGATINIB
ACTIVE SUBSTANCE / INN

BRIGATINIB

Brand name(s): Alunbrig, ALUNBRIG
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA208772
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Brigatinib
REGULATORS
FDA · EMA
SPONSORS / MAH
TAKEDA PHARMS USA, Takeda Pharma A/S
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ALUNBRIGNDA208772TAKEDA PHARMS USAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AlunbrigTakeda Pharma A/SAuthorised22/11/2018Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON BRIGATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →